×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by MORNEAU MICHAEL

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationJan 19, 2021Option Exercise$6.681,68511,256116,062Jan 19, 2021, 06:21 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationJan 04, 2021Option Exercise$5.802,73915,886117,747Jan 06, 2021, 12:00 AM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationSep 15, 2020Option Exercise$6.251,5579,73197,873Sep 16, 2020, 05:21 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationJan 19, 2020Option Exercise$7.182,04414,67692,840Jan 21, 2020, 05:35 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationJan 19, 2019Option Exercise$8.782,04417,94691,991Jan 22, 2019, 07:13 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationMay 31, 2018Sale$9.2521,551199,34794,035May 31, 2018, 07:03 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELVP, Finance and AdministrationMay 04, 2018Option Exercise$4.227,61632,14094,035May 08, 2018, 08:37 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELChief Financial OfficerMay 04, 2017Option Exercise$1.348,19210,97780,604May 05, 2017, 06:25 PM
VKTXViking Therapeutics, Inc.MORNEAU MICHAELChief Financial OfficerMay 04, 2015Option Exercise$9.4910,40498,73477,404May 06, 2015, 07:20 PM
TSRXTrius Therapeutics IncMORNEAU MICHAELVP Finance & CAOJul 11, 2013Option Exercise$6.8840,000275,00032,545Jul 12, 2013, 06:56 PM
TSRXTrius Therapeutics IncMORNEAU MICHAELVP Finance & CAOMay 14, 2013Option Exercise$5.8840,000235,00030,635May 16, 2013, 02:41 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe